Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 59,005 | -43,193 | 14,084 | 183,363 | -157,924 |
| Depreciation Amortization | 1,554 | 1,695 | 2,341 | 2,402 | 2,355 |
| Income taxes - deferred | 13,002 | 8,132 | -33,788 | -185,495 | 11 |
| Accounts receivable | 26,130 | -20,458 | -8,606 | -8,675 | -3,910 |
| Accounts payable and accrued liabilities | 142 | -6,306 | 347 | 6,031 | 1,366 |
| Other Working Capital | 24,791 | 24,809 | 1,350 | -22,575 | 689 |
| Other Operating Activity | 13,361 | 61,010 | 37,573 | 30,756 | 31,115 |
| Operating Cash Flow | $137,985 | $25,689 | $13,301 | $5,807 | $-126,298 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -187,425 | 37,924 | -29,427 | -8,064 | 149,050 |
| PPE Investments | -1,568 | -252 | -130 | -14 | -415 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -20,000 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -20,000 |
| Investing Cash Flow | $-188,993 | $37,672 | $-29,557 | $-8,078 | $128,635 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 40,753 | 17,250 | 3,701 | 3,417 | 5,885 |
| Other Financing Activity | -7,730 | -4,984 | -2,206 | -901 | 0 |
| Financing Cash Flow | $33,023 | $12,266 | $1,495 | $2,516 | $5,885 |
| Beginning Cash Position | 183,581 | 107,954 | 122,715 | 122,470 | 114,248 |
| End Cash Position | 165,596 | 183,581 | 107,954 | 122,715 | 122,470 |
| Net Cash Flow | $-17,985 | $75,627 | $-14,761 | $245 | $8,222 |
| Free Cash Flow | |||||
| Operating Cash Flow | 137,985 | 25,689 | 13,301 | 5,807 | -126,298 |
| Capital Expenditure | -1,568 | -277 | -130 | -105 | -415 |
| Free Cash Flow | 136,417 | 25,412 | 13,171 | 5,702 | -126,713 |